Retour sur lavenir.net
   WERELDHAVE BELGIUM 49.800 € (-1,58 %)     VASTNED 26.650 € (-0,93 %)     RETAIL ESTATES 61.900 € (-0,80 %)     NYXOAH 1.252 € (+4,33 %)     CIE BOIS SAUVAGE 278.000 € (-0,71 %)     UCB 200.900 € (-1,66 %)     AB INBEV 65.900 € (+1,57 %)     FAGRON 22.650 € (+0,67 %)     COLRUYT 33.240 € (-3,03 %)     PROXIMUS 5.935 € (+0,42 %)     KBC ANCORA 94.900 € (-0,63 %)     BELYSSE GROUP 0.350 € (-10,94 %)     BREDERODE 99.400 € (-0,20 %)     GIMV 45.450 € (-1,20 %)     UMICORE 21.060 € (-0,57 %)     OXURION 0.001 € (-37,50 %)     MELEXIS 68.500 € (-1,44 %)     QRF 9.840 € (-0,61 %)     IBA 15.220 € (+0,40 %)     MONTEA 61.500 € (0,00 %)     HYLORIS 4.080 € (-2,86 %)     D'IETEREN GROUP 160.700 € (-1,35 %)     ECONOCOM GROUP 1.480 € (+14,73 %)     SOFINA 241.400 € (-0,98 %)     CARE PROPERTY INV. 11.980 € (-0,83 %)     ACKERMANS V.HAAREN 260.800 € (-0,69 %)     VGP 64.400 € (-0,62 %)     JENSEN-GROUP 74.800 € (+0,81 %)     VAN DE VELDE 29.700 € (0,00 %)     RECTICEL 12.640 € (-0,47 %)     BARCO 7.130 € (-0,97 %)     TESSENDERLO 19.620 € (+0,10 %)     SOLVAY 24.600 € (-0,24 %)     AGFA-GEVAERT 0.463 € (-3,14 %)     WDP 18.800 € (+0,27 %)     ELIA GROUP 116.300 € (-1,36 %)     SIPEF 106.400 € (-0,56 %)     FLUXYS BELGIUM D 20.200 € (-1,46 %)     CENERGY 24.000 € (-0,17 %)     KBC 124.750 € (0,00 %)     WAREHOUSES ESTATES 35.200 € (-4,61 %)     GBL 68.950 € (-0,72 %)     CMB.TECH 17.820 € (+2,41 %)     LOTUS BAKERIES 12 060.000 € (0,00 %)     ORANGE BELGIUM 22.300 € (+0,45 %)     AEDIFICA 61.550 € (+0,57 %)     ONTEX GROUP 1.988 € (+7,81 %)     ARGENX SE 812.400 € (-0,37 %)     ASCENCIO 51.500 € (-1,53 %)     ENERGYVISION 17.200 € (+0,94 %)     CFE 10.650 € (+1,91 %)     BPOST 1.116 € (0,00 %)     IMMOBEL 18.700 € (+1,08 %)     HOME INVEST BE. 17.240 € (-0,12 %)     KINEPOLIS GROUP 49.000 € (+1,03 %)     SYENSQO 79.250 € (+2,13 %)     XIOR 23.150 € (+0,65 %)     DECEUNINCK 2.455 € (-1,21 %)     AZELIS GROUP 11.710 € (+0,86 %)     AGEAS 73.450 € (+0,14 %)  
   COMPAGNIE ODET 1 028.000 € (+2,59 %)     AXA 42.150 € (+0,19 %)     KERING 209.250 € (-0,50 %)     LAGARDERE SA 18.000 € (0,00 %)     PEUGEOT INVEST 51.600 € (0,00 %)     BE SEMICONDUCTOR 203.000 € (-0,88 %)     LVMH 380.900 € (+0,62 %)     ARTMARKET COM 3.270 € (-2,10 %)     AHOLD DEL 31.460 € (-0,13 %)     AIR LIQUIDE 170.760 € (+0,35 %)     BNP PARIBAS ACT.A 92.760 € (+0,76 %)     SAINT GOBAIN 66.120 € (-1,46 %)     DSM FIRMENICH AG 97.200 € (+1,08 %)     AKZO NOBEL 57.720 € (+1,83 %)     CBO TERRITORIA 3.580 € (-3,50 %)     L'OREAL 373.450 € (+0,19 %)     HEIJMANS KON 85.500 € (-3,88 %)     ING GROEP N.V. 31.035 € (+1,14 %)     BANIJAY GROUP 8.200 € (0,00 %)     HAFFNER ENERGY 0.784 € (+7,69 %)     ASML HOLDING 1 656.200 € (+0,19 %)     ARCADIS 40.100 € (+1,31 %)     TIKEHAU CAPITAL 15.640 € (-0,26 %)     GECINA 60.200 € (+1,35 %)     FORVIA 8.734 € (+1,63 %)     PROSUS 35.285 € (+2,28 %)     STIF 19.500 € (+2,69 %)     GROUPE CRIT 48.300 € (+0,21 %)     FERMENTALG 0.467 € (+2,75 %)     ARCELORMITTAL SA 57.600 € (+0,56 %)     IMCD 95.720 € (+0,53 %)     ELIS 21.420 € (+0,56 %)     VINCI 106.150 € (-0,61 %)     GTT 213.000 € (+1,43 %)     AIRBUS 189.080 € (-0,12 %)     SANOFI 69.990 € (-1,16 %)     ESSILORLUXOTTICA 144.500 € (+1,19 %)     UNILEVER 53.080 € (+0,45 %)     AUBAY 49.650 € (-0,70 %)     ACCOR 43.700 € (-1,13 %)     ABN AMRO BANK N.V. 42.350 € (+0,95 %)     HERMES INTL 1 286.000 € (-1,04 %)     INTERPARFUMS 30.100 € (+1,28 %)     VALLOUREC 18.395 € (+2,97 %)     CROSSJECT 1.310 € (0,00 %)     VEOLIA ENVIRON. 30.460 € (-0,88 %)     CREDIT AGRICOLE 16.930 € (+0,27 %)     STMICROELECTRONICS 50.870 € (+1,05 %)     EURAZEO 44.680 € (-0,27 %)     VIEL ET COMPAGNIE 18.300 € (+0,33 %)     TOTALENERGIES 75.800 € (+1,80 %)     SAFRAN 329.800 € (-0,09 %)     MR BRICOLAGE 2.840 € (-4,05 %)     BUREAU VERITAS 26.330 € (-0,90 %)     NETGEM 1.015 € (-1,93 %)     LINEDATA SERVICES 54.000 € (-0,37 %)     FOUNTAINE PAJOT 75.700 € (-3,57 %)     MGI DIGITAL GRAPHI 8.320 € (-2,46 %)     EBUSCO HOLDING 0.194 € (-0,31 %)     EDENRED 27.250 € (+0,55 %)  
News Réglementées
14/09/2026 08:05

Intuitive announces expanded indication for da Vinci SP in Europe

EQS-News: Intuitive / Key word(s): Miscellaneous/Miscellaneous
Intuitive announces expanded indication for da Vinci SP in Europe

14.09.2026 / 08:05 CET/CEST
The issuer is solely responsible for the content of this announcement.


CE mark for transvaginal gynecologic procedures expands SP's applications

AUBONNE, Switzerland, Sept. 14, 2026 /PRNewswire/ -- Intuitive, a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced CE mark approval for the indication of transvaginal gynecologic procedures for the da Vinci SP (Single Port) surgical system – marking a world's-first indication for the SP system.

Da Vinci SP

This approval expands da Vinci SP's CE-marked applications in Europe, which currently include endoscopic abdominopelvic, thoracoscopic, transoral otolaryngology, transanal colorectal, and breast surgical procedures.

"Building on the strong adoption of da Vinci SP in women's health, this approval is a meaningful step forward, not just as a regulatory milestone, but because it expands access to less invasive options for women across Europe and opens the door to potentially better recovery experiences and outcomes," said Dirk Barten, Intuitive commercial president for Europe.

The da Vinci SP system enables surgeons to perform procedures through a single incision or natural orifice, offering enhanced visualization and precision in narrow or deep anatomical spaces. Through a single-entry point, surgeons can control up to three multi-jointed instruments and a fully articulating 3DHD endoscope, enabling access to complex anatomy with minimal disruption to surrounding tissue.

"Transvaginal procedures expand the natural orifice surgery portfolio of the da Vinci SP System, which to this day includes successful transoral and transanal procedures," said Tilman Schlick, vice president, medical affairs & medical officer at Intuitive in Europe. "These less invasive, scarless surgery approaches have the potential to shorten recovery times and enhance patients' experience as they return to their daily lives. As we continue to innovate across our platforms, we remain focused on helping more patients access the benefits of minimally invasive care."

A growing body of evidence, including more than 1,000 peer-reviewed publications, supports the safety, efficacy, and patient outcomes associated with the da Vinci SP system. Da Vinci SP is also approved for use in the US, Japan, and Korea for a range of procedures spanning multiple surgical disciplines.

Images
Images accompanying this announcement are available here.

About Intuitive
Intuitive (NASDAQ:ISRG), headquartered in Sunnyvale, California, with European headquarters in Aubonne, Switzerland, is a global leader in minimally invasive care and the pioneer of robotic-assisted surgery. Our technologies include the da Vinci surgical system and the Ion endoluminal system. By uniting advanced systems, progressive learning, and value-enhancing services, we help physicians and their teams optimize care delivery to support the best outcomes possible. At Intuitive, we envision a future of care that is less invasive and profoundly better, where disease is identified early and treated quickly, so that patients can get back to what matters most.

About da Vinci Surgical Systems
There are several models of the da Vinci surgical system. The da Vinci surgical systems are designed to help surgeons perform minimally invasive surgery and offer surgeons high-definition 3D vision, a magnified view, and robotic and computer assistance. They use specialized instrumentation, including a miniaturized surgical camera and wristed instruments (i.e., scissors, scalpels, and forceps) that are designed to help with precise dissection and reconstruction deep inside the body.

For more information, please visit the company's website at www.intuitive.com/en-gb

This material may contain estimates and forecasts from which actual results may differ. Some products, features or technologies may not be available in all countries. Please contact your local Intuitive representative for product availability in your region. Refer to the product specific User Manual for indications, contraindications, warnings and other product information.

© 2026 Intuitive Surgical Operations, Inc. All rights reserved. Product and brand names/logos, including Intuitive, da Vinci, and Ion, are trademarks or registered trademarks of Intuitive Surgical or their respective owner. See intuitive.com/trademarks.

Cision View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/intuitive-announces-expanded-indication-for-da-vinci-sp-in-europe-302877010.html

rt.gif?NewsItemId=EN45140&Transmission_Id=202609140200PR_NEWS_EURO_ND__EN45140&DateId=20260914


14.09.2026 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
View original content: EQS News


2398358  14.09.2026 CET/CEST

Source : Webdisclosure.com

© 2026 Tous droits réservés
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière